KMDA

NASDAQ · Biotechnology

Kamada Ltd

Small-Cap Stocks Stocks Under $10 Biotech Stocks Healthcare Stocks

$6.87

-0.55 (-7.41%)

As of Nov 7, 2:03 AM ET ·

Analyst Consensus

Strong Buy

Analysts

Moderate

Coverage

Buy 8 89%

Hold 1 11%

Sell 0 0%

Price Target

Analyst Price Target +322.4% upside

Low Target $25.25

Average Target $29.02

High Target $47.24

Current Price $6.87

Current
$6.87

Target
$29.02

$25.25 $29.02 avg $47.24

Scenario Analysis

Bear Case

$25.25

267.5%

Low target

Base Case

$29.02

+322.4%

Avg target

Bull Case

$47.24

+587.6%

High target

Risk/Reward

2.2x

Favorable

Price in Context

52-Week High

$9.35

-26.5% from high

52-Week Low

$6.55

+4.9% from low

Target vs 52W High

$29.02

+210.4% vs high

Next Earnings Report

Nov 16, 2026

until earnings

EPS Est: $0.13

Earnings in 8 days. Analyst targets may shift significantly after the report.

Peer Consensus — Biotechnology

Stock	Consensus	Analysts	Buy %	Target	Upside
ABBV Abbvie Inc	Strong Buy	39	82%	$257.58	-11.6%
AMGN Amgen Inc	Hold	42	43%	$190.87	-58.5%
GILD Gilead Sciences Inc	Strong Buy	37	81%	$362.68	+117.3%
VRTX Vertex Pharmaceuticals Inc	Strong Buy	39	82%	$438.34	-19.9%
MRNA Moderna Inc	Hold	31	35%	$149.45	-41.2%
REGN Regeneron Pharmaceuticals	Buy	37	70%	$76.80	-91.5%
NTRA Natera Inc	Strong Buy	30	90%	$142.91	-54.0%
RVMD Revolution Medicines Inc	Strong Buy	29	93%	$114.11	-40.7%